About Fitzroy Dawkins, M.D.
Fitzroy Dawkins, M.D. is a medical oncologist and hematologist, Biotech executive and author.
He began his career at Howard University College of Medicine in Washington, D.C. where he was a practicing physician as well as an Assistant Professor of Medicine – before becoming an Associate Professor of Medicine – for 14 years. For the last four years of his tenure, he led the Division of Hematology and Oncology as the Interim Chief.
Transitioning from Howard University in 2005, he joined Johnson & Johnson Pharmaceuticals as an Associate Director in Medical Affairs. After 2 years, he transitioned to Janssen Pharmaceuticals R&D as the Director of Oncology Drug Development. For the next 5 years he led and monitored a multitude of clinical trials across melanoma, prostate cancer, and a Phase 3 global trial in ovarian cancer.
Seeking increased responsibility and personal development, he joined Incyte Corporation, a global biopharmaceutical company in Wilmington, DE as an Executive Director. In this capacity, he led multiple Phase 1, Phase 2, and Phase 3 clinical trials across various tumor types with both small and large molecules. He was privileged to be the lead Incyte physician for the company’s first FDA-approved drug, ruxolitinib, indicated in patients diagnosed with acute Graph-versus-host disease.
Continuing to seek more influence in shaping and influencing clinical trials in the African American community, Dr. Dawkins joined Forma Therapeutics, in Watertown, Massachusetts as Vice President, Clinical Development. In this capacity, he focused on sickle cell disease and prostate cancer.
At each step of his career, he has passionately advocated for: more clinical trials focused on the cancers that most affect the African American community, improved understanding of the benefits of cancer prevention, and the training of more Black physicians skilled in the science and art of clinical trials so that we can better serve our community.
Dr. Fitzroy Dawkins received his Bachelor of Science from City University of New York-York College. He completed his M.D. at the Jacobs School of Medicine and Biomedical Sciences in Buffalo, New York. He stayed on in Buffalo for the next 3 years to complete his training in internal medicine. Between 1988 and 1991 he completed a fellowship in hematology and medical oncology at the George Washington University Medical Center.
He has authored and co-authored more than 30 peer reviewed papers, with publications in the New England Journal of Medicine, Blood, Journal of Clinical Oncology, among others.
Most recently he published his first book, Fighting For Survival: Conquering Cancer And The African American Patient.
Dr. Dawkins currently lives in the Princeton area and is a Principal Clinical Consultant with ELIQUENT Life Sciences (formerly Data Revive).
Fitzroy Dawkins, M.D. 